# Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Sep 30, 2017

- Company: [Thermo Fisher Scientific Inc.](/companies/tmo.md) (CIK 97745)
- Form: 10-Q
- Filed: 2017-11-03
- Accepted by EDGAR: Nov 3, 2017, 13:48 ET
- Period: 2017-09-30
- Accession: 0000097745-17-000047
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97745/000009774517000047/q3201710q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97745/000009774517000047/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-07-02 to 2017-09-30 | $2.17bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2017-01-01 to 2017-09-30 | $6.55bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months, 2017-07-02 to 2017-09-30 | $218.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2017-01-01 to 2017-09-30 | $655.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-07-02 to 2017-09-30 | $1.40bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2017-01-01 to 2017-09-30 | $4.02bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-07-02 to 2017-09-30 | $636.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2017-01-01 to 2017-09-30 | $2.01bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-07-02 to 2017-09-30 | $156.7m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2017-01-01 to 2017-09-30 | $425.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-07-02 to 2017-09-30 | −$53.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2017-01-01 to 2017-09-30 | −$88.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-07-02 to 2017-09-30 | $533.9m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months, 2017-01-01 to 2017-09-30 | $1.70bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2017-07-02 to 2017-09-30 | $1.34 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2017-01-01 to 2017-09-30 | $4.29 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-07-02 to 2017-09-30 | $1.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2017-01-01 to 2017-09-30 | $4.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-07-02 to 2017-09-30 | 399,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2017-01-01 to 2017-09-30 | 395,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2017-01-01 to 2017-09-30 | $2.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2017-01-01 to 2017-09-30 | $292.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2017-01-01 to 2017-09-30 | $177.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2017-01-01 to 2017-09-30 | $750.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-09-30 | $741.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-09-30 | $8.84bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-09-30 | $55.99bn | us-gaap:Assets |
| Current liabilities | at 2017-09-30 | $7.03bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2017-09-30 | $2.76bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-09-30 | $24.70bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2017-09-30 | 400,995,357 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/97745/000009774517000047/q3201710q.htm

Filed Nov 3, 2017.
Source: SEC EDGAR, the filing index for accession 0000097745-17-000047. Last ingested by Listed: Nov 14, 2026, 12:05 ET. No prices; not investment advice.
